RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
AngioDynamics Stock

AngioDynamics Equity 2024

AngioDynamics Equity

378.3 M USD

Ticker

ANGO

ISIN

US03475V1017

WKN

A0B9A5

In 2024, AngioDynamics's equity was 378.3 M USD, a -10.88% increase from the 424.5 M USD equity in the previous year.

AngioDynamics Aktienanalyse

What does AngioDynamics do?

AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing AngioDynamics's Equity

AngioDynamics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding AngioDynamics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating AngioDynamics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

AngioDynamics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in AngioDynamics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about AngioDynamics stock

What is the equity of AngioDynamics this year?

AngioDynamics has equity of 378.3 M USD this year.

What was the equity of AngioDynamics compared to the previous year?

The equity of AngioDynamics has increased/decreased by -10.88% decreased compared to the previous year.

What impact does a high equity have on investors of AngioDynamics?

A high equity is advantageous for investors of AngioDynamics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of AngioDynamics?

A low equity can be a risk for investors of AngioDynamics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of AngioDynamics affect the company?

An increase in equity of AngioDynamics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of AngioDynamics affect the company?

A reduction in equity of AngioDynamics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of AngioDynamics?

Some factors that can affect the equity of AngioDynamics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of AngioDynamics so important for investors?

The equity of AngioDynamics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can AngioDynamics take to change the equity?

To change equity, AngioDynamics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does AngioDynamics pay?

Over the past 12 months, AngioDynamics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, AngioDynamics is expected to pay a dividend of 0 USD.

What is the dividend yield of AngioDynamics?

The current dividend yield of AngioDynamics is .

When does AngioDynamics pay dividends?

AngioDynamics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AngioDynamics?

AngioDynamics paid dividends every year for the past 0 years.

What is the dividend of AngioDynamics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is AngioDynamics located?

AngioDynamics is assigned to the 'Health' sector.

Wann musste ich die Aktien von AngioDynamics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AngioDynamics from 7/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/16/2024.

When did AngioDynamics pay the last dividend?

The last dividend was paid out on 7/16/2024.

What was the dividend of AngioDynamics in the year 2023?

In the year 2023, AngioDynamics distributed 0 USD as dividends.

In which currency does AngioDynamics pay out the dividend?

The dividends of AngioDynamics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von AngioDynamics

Our stock analysis for AngioDynamics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AngioDynamics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.